Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
3 S&P 500 Stocks to Target This Week
3 S&P 500 Stocks to Target This Week
3 S&P 500 Stocks to Target This Week
Kayode Omotosho
Tue, February 24, 2026 at 1:41 PM GMT+9 3 min read
In this article:
^GSPC
-1.04%
GLW
+4.11%
INCY
-0.47%
MCD
+1.62%
The S&P 500 (^GSPC) is full of established businesses, but only some continue to outperform the market. A few standout companies are thriving thanks to strong fundamentals and sustained competitive advantages.
Not every big company is a great investment, and we’re here to help you find the best opportunities. That said, here are three S&P 500 stocks positioned to outperform.
McDonald’s (MCD)
Market Cap: $238.3 billion
With nicknames spanning Mickey D’s in the U.S. to Makku in Japan, McDonald’s (NYSE:MCD) is a fast-food behemoth known for its convenience and broken ice cream machines.
Why Could MCD Be a Winner?
McDonald’s stock price of $334.38 implies a valuation ratio of 24.9x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Corning (GLW)
Market Cap: $124.6 billion
Supplying windows for some of the United States’s earliest spacecraft, Corning (NYSE:GLW) provides glass and other electronic components for the consumer electronics, telecommunications, automotive, and healthcare industries.
Why Is GLW on Our Radar?
Corning is trading at $146.56 per share, or 44.9x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Incyte (INCY)
Market Cap: $20.07 billion
Founded in 1991 and evolving from a genomics research firm to a commercial-stage drug developer, Incyte (NASDAQ:INCY) is a biopharmaceutical company that discovers, develops, and commercializes proprietary therapeutics for cancer and inflammatory diseases.
Why Are We Positive On INCY?
At $100.38 per share, Incyte trades at 13.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Terms and Privacy Policy
Privacy Dashboard
More Info